Clik here to view.
Macrovascular Disease – Therapeutic Potential of cEPCs: Reduction Methods for...
An Investigation of the Potential of circulating Endothelial Progenitor Cells (cEPCs) as a Therapeutic Target for Pharmacological Therapy Design for Cardiovascular Risk Reduction: A New Multimarker...
View ArticleClik here to view.
Cardiovascular Outcomes: Function of circulating Endothelial Progenitor Cells...
This is a post in Clinical Cardiology Frontiers: Resident-Cell-based Therapy and Molecular Cardiology An Overview of the State of Science on Circulating Endothelial Progenitor Cells (cEPCs) and...
View ArticleClik here to view.
Positioning a Therapeutic Concept for Endogenous Augmentation of cEPCs —...
Macrovascular Disease – Therapeutic Potential of cEPCs: Promise for CV Risk Reduction Author and Investigator Initiated Study: Aviva Lev-Ari, PhD, RN Introduction Biomarker Discovery – a comprehensive...
View ArticleClik here to view.
Accurate Identification and Treatment of Emergent Cardiac Events
Accurate Identification of Emergent Cardiac Events Author: Larry H Bernstein, MD, FACP http://pharmaceuticalintelligence.com/2013/03/15/accurate-ident…cardiac-events/ In the immediately preceding...
View ArticleClik here to view.
Circulating Endothelial Progenitors Cells (cEPCs) as Biomarkers
Circulating Endothelial Progenitors Cells (cEPCs) as Biomarkers Article Curator: Larry H. Bernstein, MD, FCAP and Topic Curator: Aviva Lev-Ari, PhD, RN Circulating progenitor cells have gained much...
View Article
